Time is fast slipping away for finding workable solutions to address antimicrobial resistance, and the World Economic Forum’s annual meeting this week offers a rare opportunity to spur action, says Lars Rebien Sørensen, chairman of the Novo Nordisk Foundation. The foundation is sponsoring a panel debate on AMR on the first day of the elite gathering in Davos, Switzerland, in hopes of spurring real action on the issue.
The annual World Economic Forum from 21-24 January will be attended by heads of state, global business leaders and others...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
